aod9604 academic study Peptide Fragment for Metabolic Pathway Research Produced using quality AOD 9604 (5mg) - House

Verify you are using the correct syringe markings

AOD-9604 Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse AOD-9604 doses across species and administration routes: Rodent studies: 250-500 mcg/kg orally or intraperitoneally was most common for obesity research Rabbit models: 0.25 mg per joint for osteoarthritis studies (intra-articular injection) Pig pharmacokinetic studies: 1.5 mg/kg IV and 2 mg/kg oral for metabolism characterization Human clinical trials: Oral doses of 0.25-10 mg daily

These animals are fed a high-fat diet until they become obese, then randomized to receive either 5-amino-1mq or a control treatment

Furthermore, stacking it with other peptides or stimulants increases complexity and risk

Research has confirmed no significant effects on serum IGF-1 levels, no negative effect on carbohydrate metabolism, and no immunogenicity with no anti-AOD-9604 antibodies detected in any participants